| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 01/19/2005 | CN1566099A Isoquinoline-1, 3, 4-trione compounds, preparation method and uses thereof |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1185230C N-substituted carbamoyloxyalkyl-azolium derivs. |
| 01/19/2005 | CN1185228C Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 01/19/2005 | CN1185220C Para-amino substituted phenylamide glucokinase activators |
| 01/19/2005 | CN1185217C Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
| 01/19/2005 | CN1185216C Fungicides |
| 01/18/2005 | US6844357 Anticarcinogenic agents |
| 01/18/2005 | US6844347 Substituted 4-amino-2aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 01/18/2005 | US6844344 Depression, anxiety; tobacco or nicotine withdrawal; such as 1-(benzofuran-4-yl)oxy-3-(4-(6-methoxybenzo(b)thiophen-2-yl)piperidinyl)-2 -propanol oxalate |
| 01/18/2005 | US6844342 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
| 01/18/2005 | US6844338 Piperidyindoles as serotonin receptor ligands |
| 01/18/2005 | US6844295 2-Pyridin-2-yl derivatives |
| 01/13/2005 | WO2005003128A1 Thiazolylpiperidine derivatives as mtp inhibitors |
| 01/13/2005 | WO2005003127A1 Bicyclic heteroaromatic derivatives as modulators of cxcr3 function |
| 01/13/2005 | WO2005003118A1 Amide-substituted 1,2,4-triazin-5(2h)-ones for the treatment of chronically inflammatory diseases |
| 01/13/2005 | WO2005003103A2 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases |
| 01/13/2005 | WO2005003102A1 Methods of preparation of dehydro-diketopiperazines in liquid phase or of solid supported phase |
| 01/13/2005 | WO2005003097A1 Cis-2,4,5-triaryl-imidazolines |
| 01/13/2005 | WO2005003087A2 Oxazole derivatives as antibacterial agents |
| 01/13/2005 | WO2005003071A1 Method for producing c1-c15 fragments of epothilones and the derivatives thereof |
| 01/13/2005 | WO2005002577A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 01/13/2005 | WO2004099192A3 Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 01/13/2005 | WO2004099134A3 Glutaminyl based dp iv-inhibitors |
| 01/13/2005 | WO2004092130A3 N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders |
| 01/13/2005 | WO2004064764A3 Substituted alkyl amido piperidines |
| 01/13/2005 | WO2004050035A3 Benzimidazoles and analogs thereof as antivirals |
| 01/13/2005 | US20050009892 Phenyloxazole derivatives lower blood triglyceride, glucose, insulin; hyperlipidemia, arteriosclerosis, diabetes mellitus, hypertension, obesity; 2-methyl-2-[6-(5-methyl-2-phenyloxazol-4-yl)-(E)-4-hexenyloxy]propionic acid |
| 01/13/2005 | US20050009890 E.g., 1) (2R)-N-(4-phenoxybenzyl)-3-cyclohexylmethylthio-2-((4R)-3-methoxymethylcarbonylthiazolidin-4-ylcarbonylamino)propanamide; treatment of cerebral infarct, transient ischemic attack, encephalomyelopathy, spinal angiopathy, hypertension with stress, neurosis, epilepsy, asthma, pollakiuria, and pain |
| 01/13/2005 | US20050009876 Indazole compounds, compositions thereof and methods of treatment therewith |
| 01/13/2005 | US20050009874 Tetrahydropyridin or piperidino heterocyclic derivatives |
| 01/13/2005 | US20050009873 1-Acyl-2,4-dicarbonyldihydropyrrole derivatives, e.g., rel-(2S,5R)-1-(4-tert-butylbenzoyl)-2-isobutyl-5-(1,3-thiazol-2-yl)-2,5-dihydro-1H-pyyrole-2,4-dicarboxylic acid; properation by acylating the corresponding dihydropyrrole derivative |
| 01/13/2005 | US20050009870 3-(amino)sulfonylamino-substituted, e.g., N-(1,6-Dibenzyl-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)-benzenesulfonamide and N-(1-Benzyl-2-oxo-6-(thiophen-3-yl)-1,2,3,4-tetrahydroquinolin-3-yl)benzenesulfonamide; eating, metabolic, obesity, cognitive, neurological, pain, inflammatory and psychiatric disorders |
| 01/13/2005 | US20050009867 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 01/13/2005 | US20050009864 Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 01/13/2005 | US20050009855 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives; these compounds interfere with the E1-E2-DNA complex during initiation of DNA replication |
| 01/13/2005 | US20050009853 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 01/13/2005 | US20050009843 Thiazole derivatives of pyrido-1,2-a-pyrimidines, quinolones, pyridopyridazinoness, cinnolinones and naphthyridones; identifying a drug efflux pump expressed in a microorganism |
| 01/13/2005 | US20050009840 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer |
| 01/13/2005 | US20050009839 Novel azoles having an insecticidal action |
| 01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/13/2005 | US20050009834 E.g., 3-(2-chloro-6-fluorophenyl)-1-[4-(3,5-dichloropyridin-2-yloxymethyl)phenyl]-5-methyl-1H-1,2,4-triazole and 3-(3-chloropyridin-2-yl)-1-[4-(3-chloro-5-trifluoromethylpyridin-2-yloxymethyl)phenyl]-5-methyl-1H-1,2,4-triazole; for use as pesticides, especially insecticides and acaricides |
| 01/13/2005 | US20050009829 1-Substituted 2-carboxamide derivatives of fused ring imidazoles, e.g., -[5-(5-Chloro-thiophen-2-yl)-isoxazol-3-ylmethyl]-1H-benzoimidazole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide |
| 01/13/2005 | US20050009821 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 01/13/2005 | US20050009820 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 01/13/2005 | US20050009818 Therapeutic heterocyclic compounds |
| 01/13/2005 | US20050009817 Substituted heteroaryls |
| 01/13/2005 | US20050009816 Potassium channel modulators |
| 01/13/2005 | US20050009785 Heterocyclic compounds |
| 01/13/2005 | US20050009756 Polymorph of a pharmaceutical |
| 01/13/2005 | US20050009058 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds |
| 01/13/2005 | DE10327472A1 New thia-epothilone derivatives useful in the preparation of medicaments for the treatment of cancer |
| 01/13/2005 | CA2531078A1 Method for producing c1-c15 fragments of epothilones and the derivatives thereof |
| 01/13/2005 | CA2530886A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 01/13/2005 | CA2530816A1 Amide-substituted 1,2,4-triazin-5(2h)-ones for the treatment of chronic inflammatory diseases |
| 01/13/2005 | CA2528119A1 Cis-2,4,5-triaryl-imidazolines |
| 01/12/2005 | EP1496053A1 Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 01/12/2005 | EP1496052A1 Novel aminobenzamide derivative |
| 01/12/2005 | EP1495018A1 Tricyclic thrombin receptor antagonists |
| 01/12/2005 | EP1495005A1 Pyrazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1495002A1 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/12/2005 | EP1495001A1 Antibacterial agents |
| 01/12/2005 | EP1494671A1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists |
| 01/12/2005 | EP1494668A2 Use of benzimidazole analogs in the treatment of cell proliferation |
| 01/12/2005 | EP1494667A1 Imidazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1494663A1 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss |
| 01/12/2005 | EP1434773A4 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 01/12/2005 | EP1353918B1 Morpholine derivatives as antagonists of orexin receptors |
| 01/12/2005 | CN1564820A Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 01/12/2005 | CN1564817A Novel benzothiazine derivatives, their preparation and use |
| 01/12/2005 | CN1564816A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 01/12/2005 | CN1564811A Acylsulfonamides as inhibitors of steroid sulfatase |
| 01/12/2005 | CN1563003A Suitable industrialized method of preparing Lamivudine |
| 01/12/2005 | CN1184215C Substd. oxazoles and thiazoles derivs. as HPPAR alpha activators |
| 01/12/2005 | CN1184214C Alpha-acyl and alpha-heteroatom-bustituted benzene acetamide glucokinase activators |
| 01/12/2005 | CN1184204C Piperidine compounds for use as CCR-3 inhibitors |
| 01/12/2005 | CN1183989C Reaction crystallizing method for improving grain size |
| 01/11/2005 | US6841682 Prevent binding of adrenergenic receptors |
| 01/11/2005 | US6841674 N-heterocyclic derivatives as NOS inhibitors |
| 01/11/2005 | US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 01/11/2005 | US6841566 Viral polymerase inhibitors |
| 01/11/2005 | US6841564 Tri-aryl-substituted-ethane PDE4 inhibitors |
| 01/11/2005 | US6841560 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 01/11/2005 | CA2269128C Piperazino derivatives as neurokinin antagonists |
| 01/11/2005 | CA2104909C Decahydroisoquinolines as excitatory amino acid receptor antagonists |
| 01/11/2005 | CA2100924C Oxadiazine derivatives |
| 01/06/2005 | WO2005000852A2 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 01/06/2005 | WO2005000844A1 Process for the preparation of insulin sensitizer and intermediate compound thereof |
| 01/06/2005 | WO2005000843A2 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 01/06/2005 | WO2005000842A1 Benzothiazole derivatives as adenosine receptor ligands |
| 01/06/2005 | WO2005000826A1 Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors |
| 01/06/2005 | WO2005000821A1 Tachykinin receptor antagonists |
| 01/06/2005 | WO2005000309A2 Chemical compounds |
| 01/06/2005 | WO2005000298A2 5-membered heterocycle-based p-38 inhibitors |
| 01/06/2005 | WO2005000249A2 Preparation of chemical compounds |
| 01/06/2005 | WO2004101528A3 Isoquinoline derivatives and their use as gfat inhibitors |
| 01/06/2005 | WO2004087646A3 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases |
| 01/06/2005 | WO2004060281A3 2-aryl thiazole derivatives as kcnq modulators |
| 01/06/2005 | WO2003042177A8 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/06/2005 | US20050004360 Compounds and methods for modulation of estrogen receptors |